Interstitial Lung Disease Clinical Trials in Montreal, Quebec
7 recruitingMontreal, Quebec, Canada
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Interstitial Lung DiseasesFamilial Pulmonary FibrosisInterstitial Lung Abnormalities
Boehringer Ingelheim80 enrolled56 locationsNCT07201922
Recruiting
Phase 3
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Progressive Pulmonary FibrosisInterstitial Lung Disease
United Therapeutics698 enrolled152 locationsNCT05943535
Recruiting
Phase 2
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Progressive Pulmonary FibrosisInterstitial Lung DiseasePulmonary Fibrosis+4 more
Avalyn Pharma Inc.375 enrolled152 locationsNCT06329401
Recruiting
Phase 2
Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease
Lung CancerInterstitial Lung Disease
David Palma98 enrolled3 locationsNCT05986318
Recruiting
Not Applicable
Routine vs On-demand ECMO for Lung Transplantation
Respiratory FailurePulmonary FibrosisInterstitial Lung Disease (ILD)
Centre hospitalier de l'Université de Montréal (CHUM)218 enrolled4 locationsNCT06615492
Recruiting
Phase 2
Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
Interstitial Lung DiseaseSystemic SclerosisSystemic Sclerosis With Lung Involvement
Centre hospitalier de l'Université de Montréal (CHUM)35 enrolled3 locationsNCT05785065
Recruiting
ILD-SARDs Registry and Biorepository
Interstitial Lung DiseaseRheumatic ArthritisSystemic Lupus Erythematosus+6 more
McGill University Health Centre/Research Institute of the McGill University Health Centre252 enrolled1 locationNCT05007340